26 Jun LIGHTWAVE Study

About the LIGHTWAVE Study

The clinical research study lasts up to 20 weeks, with up to 7 visits to the study site and 2 phone check-ins. Additionally, there will be assessments done using a mobile device between visits. The investigational drug is a capsule taken by mouth once a day. The safety and efficacy of the investigational oral drug have not been established. There is no guarantee that the outcome of studies will result in approval by a health authority. Your loved one’s eligibility to participate will be determined during the Screening Period. During this visit to the study site, they will:

• Meet with the study doctor and study staff
• Review eligibility criteria
• Undergo an initial evaluation and assessments
• Complete the study questionnaires
  
  

As your loved one’s study partner, your role will be to help answer questions about them or otherwise guide their participation if they are confused or unable to do s6 themselves.

Does My Loved One Qualify?

Your loved one may be eligible to participate if they:

• Are 50 to 80 years of age
• Have been diagnosed with mild cognitive impairment or mild dementia due to Alzheimer’s disease (a study doctor can evaluate them if they haven’t been diagnosed)
• Are able to walk*
• Have a study partner (like you) willing to attend and assist with study activities\

*Canes and walkers are permitted; wheelchairs are not. A study doctor can discuss additional eligibility requirements with you and your loved one.

If Your Loved One Qualifies and Decides to Participate:

• A study doctor will closely monitor your loved one, their symptoms, and their overall health
• All study-related procedures and the investigational oral drug will be provided at no cost
• Transportation assistance may be available, if needed
• Your role as the study partner will be to accompany your loved one to study visits and answer questions that they may be unable to answer themselves

Your and your loved one’s safety are the highest priority while participating. If you or they have questions or concerns at any point throughout the clinical research study, please speak with a study staff member. The study staff can also tell you and your loved one about their specific COVID-19 safety protocols. Your loved one’s participation in the LIGHTWAVE Study is completely voluntary. If they decide to participate in this clinical research’ study, they are free to withdraw at any time, for any reason, without any penalty or effect on their medical care. Talk to your loved one’s doctor if you have any questions about Alzheimer’s disease or its symptoms, or about participating in this trial.